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Abstract
Background: The aim of this study was to explore biochemical changes in the cerebrospinal fluid
(CSF) induced by shunt surgery and the relationship between these changes and clinical
improvement.
Methods:  We measured clinical symptoms and analysed lumbar CSF for protein content,
neurodegeneration and neurotransmission markers in patients with secondary (SNPH, n = 17) and
idiopathic NPH (INPH, n = 18) before and 3 months after shunt surgery. Patients were divided into
groups according to whether or not there was improvement in clinical symptoms after surgery.
Results: Preoperatively, the only pathological findings were elevated neurofilament protein (NFL),
significantly more so in the SNPH patients than in the INPH patients, and elevated albumin content.
Higher levels of NFL correlated with worse gait, balance, wakefulness and neuropsychological
performance. Preoperatively, no differences were seen in any of the CSF biomarkers between
patients that improved after surgery and those that did not improve. Postoperatively, a greater
improvement in gait and balance performance correlated with a more pronounced reduction in
NFL. Levels of albumin, albumin ratio, neuropeptide Y, vasoactive intestinal peptide and ganglioside
GD3 increased significantly after shunting in both groups. In addition, Gamma amino butyric acid
increased significantly in SNPH and tau in INPH.
Conclusion: We conclude that a number of biochemical changes occur after shunt surgery, but
there are no marked differences between the SNPH and INPH patients. The results indicate that
NFL may be a marker that can predict a surgically reversible state in NPH.
Background
Normal pressure hydrocephalus (NPH) is a common and
treatable cause of cognitive impairment and gait distur-
bance in the elderly[1]. NPH is generally thought of as a
disorder resulting from disturbed cerebrospinal fluid
(CSF) dynamics. Cerebral blood flow (CBF) is reduced in
white and gray matter regions [2-5]. Microdialysis studies
indicate compromised metabolism in the periventricular
region [6]. Magnetic resonance (MR) images showing
periventricular white matter lesions (WML) are a hallmark
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of NPH, the extent of which correlate with symptomath-
ology [7-9]. After surgery, patients show increased CBF
and reductions in periventricular WML in parallel with
clinical improvement that are compatible with a restitu-
tion of brain function [2-5,8,9].
Previous studies on CSF composition in NPH patients
have shown a variety of changes that indicate astrogliosis
[10,11], axonal degeneration [11], inflammation [12] but
no major demyelination [13]. Peptidergic neurotransmis-
sion is disturbed [14-16], whereas monoamine metabo-
lites remain normal [13,17]. In a recent paper with the
same group of patients [18], we studied the relationship
between biomarkers in ventricular CSF and periventricu-
lar MRI pathology and explored concentration gradients
of these markers between the ventricular and lumbar CSF.
A correlation was found between the extent of periven-
tricular WML and neurofilament protein (NFL) concen-
tration in ventricular CSF, which corroborates a previous
study on lumbar CSF [9].
There is considerable interest in investigating the diagnos-
tic and predictive value of CSF markers in NPH. In a pre-
vious study, we reported that high preoperative CSF levels
of the axonal marker, NFL correlated with the severity of
symptoms and also with a favourable outcome after sur-
gery indicating that the symptoms in NPH are associated
with an ongoing but reversible axonal dysfunction [11].
This view is further supported by the correlations found
between high CSF NFL, extended periventricular white
matter lesions and pronounced symptoms in NPH
patients [8,9,18]. To what degree the altered CNS metab-
olism and CSF dynamics induced by shunt surgery can
influence the concentrations of axonal markers has not
yet been studied to our knowledge. It is reasonable to pre-
dict that the increased levels of neuronal CSF markers
reported in NPH decrease towards normal in parallel with
clinical improvement, following shunt surgery. Further, it
could be hypothesized that concentrations of neurotrans-
mitter metabolites are associated with severity of symp-
toms.
The aim of the present study was to investigate in both
SNPH and INPH patients 1) the preoperative levels of
lumbar CSF markers reflecting neurodegeneration and
neurotransmission, and clinical improvement after sur-
gery; 2) the changes in lumbar CSF marker concentrations
induced by surgery; and 3) correlations between lumbar
CSF changes and clinical improvement after surgery. The
patients included in this study are the same as in a previ-
ous paper [18] which examined ventricular CSF concen-
trations and white matter pathology before and after
shunt surgery and the relationship between lumbar and
ventricular CSF markers.
Methods
Patients
Thirty-five consecutive patients diagnosed with NPH at
the Hydrocephalus Research Unit, Sahlgrenska University
Hospital, Goteborg, Sweden, and who had a repeat CSF
examination were included (table 1). These are the same
patients as reported in a previous paper [18]. All patients
received a ventriculo-peritoneal shunt: a Sophy™ Pro-
grammable Pressure Valve (Sophysa, Orsay Cedex,
France) or a Delta Valve (Medtronic PS Medical, Santa
Barbara, USA). The Göteborg University Ethics Commit-
tee approved the study and verbal informed consent was
obtained from all patients.
Study protocol
Diagnostic criteria for NPH have been described previ-
ously [8] and were a) gait disturbance; b) mental deterio-
ration, or urinary incontinence, or both; c) enlarged
ventricles on computerised tomography (CT) or MRI with
Table 1: Demographic features of patients.
Secondary NPH (n = 17) Mean (SD), frequency Idiopathic NPH (n = 18) Mean (SD), frequency
Age (years) 65 (10); range 49–79 68 (15.7); range 19–86
Males/Females 12/5 11/7
Duration of symptoms (months) 16 (19); range 2–60 40 (37); range 11–164
Etiology
Subarachnoid hemorrhage 9 (53%)
Cerebrovascular disorder 4 (23%)
Trauma 2 (12%)
Other* 2 (12%)
Cerebrovascular risk factors
Hypertension 4 (23%) 5 (28%)
Cardiovascular disorder 3 (18%) 5 (28%)
Diabetes 1 (6%) 2 (11%)
Cerebrovascular disorder etiology was considered when there was a temporal relationship between an ischemic or hemorrhagic incident other 
than subarachnoid hemorrhage and development of NPH symptoms. * Meningioma (n = 1) and Recklinghausen's disease (n = 1). These are the 
same patients as reported in a previous paper [18].Cerebrospinal Fluid Research 2008, 5:9 http://www.cerebrospinalfluidresearch.com/content/5/1/9
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Evan's index > 0.30; d) a lumbar CSF pressure < 20 cm
H2O; e) ventricular filling and block of convexity flow on
radionuclide cisternography (RC). The CSF tap test [19]
and regional cerebral blood flow (rCBF) measurement
was performed on some patients with signs of other disor-
ders, such as vascular lesions. Only patients with improve-
ment at the CSF tap test and a characteristic pattern on
rCBF (n = 11) [2] were included. The probable cause of the
NPH state was assessed and patients were diagnosed with
idiopathic etiology (INPH) if no known cause could be
identified. Three months postoperatively, a re-examina-
tion was performed using the same protocol except RC. If
a patient had not improved clinically and the ventricular
system had not decreased in size at the re-examination,
the shunt was tested by radionuclide shuntography and
was surgically corrected if malfunctioning. Using the clin-
ical measures described below, patients were divided into
two groups for data analysis: those improved by shunt
surgery or those unimproved by surgery.
Clinical measures
Patients were evaluated before and three months after sur-
gery according to a previously published study protocol
[13,20,21] comprising a semi quantitative evaluation of
twelve symptoms and signs measuring gait, balance, men-
tal and bladder performance. Mini-Mental State Examina-
tion (MMSE) was used to assess global psychometric
performance. Simple reaction time was calculated as the
median of 10 tests using simultaneous sound and light
stimuli. The other psychometric tests used were the iden-
tical forms test (perceptual speed and accuracy) and Bing-
ley's test (learning and memory) [11]. Bingley's visual
recognition test was performed by presenting a picture of
12 drawings of familiar objects over a 30 second period.
Recognition was tested immediately. Each test was done
twice and the mean calculated. The impairment of wake-
fulness was assessed as presence of somnolence-sopor-
coma disorder (SSCD) based on the original coarse divi-
sion of SSCD into a mild, a moderate and a severe form by
Lindquist and Malmgren [22]. Clinical indices reflecting
global, psychometric, balance, gait and continence per-
formance were calculated as previously described [20]
(Table 2; see Statistics).
CSF analysis
Lumbar puncture (LP) was performed in the L3/L4 or L4/
L5 interspace with the patient in a recumbent position on
the morning before, and three months after shunt surgery.
The CSF pressure was measured and the first 12 ml of CSF
were collected in ice-chilled tubes, aliquoted, centrifuged
and frozen at -80° until analyzed.
The CSF concentrations of the major monoamine metab-
olites, homovanillic acid (HVA), 5-hydroxy-indoleacetic
acid (5-HIAA) and 4-hydroxy-3-methoxyphenylglycol
(HMPG) [23], sulphatide [24], neuropeptide Y (NPY)
[25], vasoactive intestinal peptide (VIP) [14], tau protein
[26], ganglioside GD3 (GD3) [27], gamma amino butyric
acid (GABA) [13] and neurofilament protein (NFL) [28]
were determined as previously described. Albumin in
serum and CSF was determined by nephelometry. The
CSF/serum albumin ratio [29] was used as a measure of
the blood-brain barrier (BBB) integrity [29].
Statistics
Nonparametric Mann-Whitney U test was used for
between group comparisons. Spearman correlation coeffi-
cients were calculated in correlation analyses. Changes
between pre- and postoperative values were analyzed by
Wilcoxon signed rank sum test. The clinical indices were
constructed by calculating the mean of the variables
included in each index (Table 2). Scores were standard-
ized to enable comparisons across indices [20]: preopera-
tive variables were z-standardized (mean of 0 and a
Table 2: Clinical characteristics of SNPH and INPH patients pre- and postoperatively.
Index Function/Test Preop SNPH (n = 17) Preop INPH (n = 18) Postop SNPH (n = 17) Postop INPH (n = 18)
Global MMSE (0–30) 17.2 (9.6) 23.3 (7.4) * 23.3 (4.6) ** 25.9 (7.9) **
Psycho-metric Identical forms test (0–60) 14.4 (17.8) 24.4 (12.3) 20.9 (17.3) ns 32.3 (12.1) ns
Bingley's test (0–12) 1.9 (2.1) 4.0 (2.1) * 3.9 (1.7) ** 4.4 (1.8) ns
Reaction time test (s) 1.7 (3.0) 1.4 (1.8) 0.5 (0.7) ns 0.9 (1.3) ns
Balance Romberg's test (0–60) 24.9 (27.2) 42.8 (26.1) 41.1 (25.5) ** 50.4 (22.0) **
Gait Gait performance (1–6) 3.4 (1.8) 2.4 (1.2) * 2.2 (1.5) ** 1.8 (1.1) ns
Time needed to walk 10 m (s) 38.5 (43.1) 23.4 (35.3) 11.4 (2.2) * 12.6 (4.2) *
Steps needed to walk 10 m (#) 42.8 (38.1) 30.1 (22.4) 19.9 (3.7) ** 19.5 (4.6) **
Cont-inence Urgency incontinence (yes/no) 4/11 8/10 * 11/5 * 5/13 ns
Wake-fulness IW (1/2/3/4) 4/7/3/3 9/7/2 * 14/3/0/0 ** 14/4/0/0 *
MoD 0.75 (0.72) 0.33 (0.37)
Values are given as Mean (SD) or frequency. Gait performance is registered as 1–6: 1 = normal; 2 = insecure; 3 = insecure cane; 4 = bimanual 
support; 5 = aided; 6 = wheelchair. 1–4: 1 = none; 2 = slight; 3 = moderate; 4 = severe. IW = Impairment of wakefulness (1 = none; 2 = slight; 3 = 
moderate; 4 = severe). MoD = mean of differences which is a measure of overall improvement (see statistics). Significant differences between SNPH 
and INPH patients preoperatively are indicated in the Preop INPH column. Differences between the pre- and postoperative assessment were 
analysed for SNPH and INPH patients as indicated in the Postop columns. ns = non significant; * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001.Cerebrospinal Fluid Research 2008, 5:9 http://www.cerebrospinalfluidresearch.com/content/5/1/9
Page 4 of 8
(page number not for citation purposes)
standard deviation of 1.0) and postoperative variables
were standardized using the mean and SD of the preoper-
ative variables. The difference between the pre- and post-
operative values was calculated for each index, and the
mean of the differences (MoD) was calculated as the over-
all result after shunt surgery. Patients showing MoD >
0.05 were considered improved, which corresponded to
the clinical impression in each case. A p-value < 0.05 was
considered significant.
Results
Clinical measures
Clinical assessments of patient groups are given in Table
2. Preoperatively, the INPH patients were significantly
better than the SNPH patients for MMSE, Bingley's test,
gait performance and wakefulness but were significantly
worse for continence.
After shunt surgery, 28 patients (80%) were improved
(MoD 0.12 to 2.4), 5 (14%) were unchanged (MoD -0.04
to 0.04) and 2 (6%) deteriorated (MoD -0.19 and -0.45,
data not shown). Fifteen of the SNPH patients were
improved, whereas 2 deteriorated (MoD -0.19 to -0.45).
Thirteen (72%) of the INPH patients improved, whereas
5 (28%) were unchanged (MoD -0.03 to 0.03, data not
shown). The overall improvement (MoD) for all patients
was 0.53 ± 0.60 (mean ± SD) without any significant gen-
der differences (data not shown). Secondary NPH patients
(MoD = 0.75 ± 0.72) showed more overall improvement
than INPH patients, but the difference was not significant
(MoD = 0.33 ± 0.37), Table 2. Specifically, eight tests were
significantly improved in the SNPH patient compared to
five in the NPH patients.
CSF biomarkers pre- and postoperatively
Preoperatively in both groups, the only pathological find-
ings were elevated neurofilament protein (NFL) and ele-
vated albumin (Table 3). SNPH patients also had an
elevated albumin ratio. Apart from this, the only differ-
ence seen between SNPH and INPH patients was in NFL,
which was higher in secondary cases (4884 ± 5855 vs
1352 ± 2989 ng/L, p = 0.01, Table 3). Preoperatively, there
were no differences in any CSF biomarker between
patients that improved and those that did not improve
after surgery. Patients with cerebrovascular etiology (n =
4) versus those without, had higher sulphatide (287.5 ±
85.4 vs 197.2 ± 97.2 nmol/l; n.s.) and albumin ratios
(12.3 ± 2.9 vs 9.9 ± 8.6; p = 0.09, data not shown).
After surgery, significant increases were seen in both
SNPH and INPH groups for albumin, albumin ratio, NPY,
VIP, GD3. On the other hand, HVA, HMPG and 5-HIAA
and sulphatide remained unchanged (Table 3). In addi-
tion, GABA was significantly increased in SNPH patients
and tau in the INPH patients. These postoperative changes
were significant also in the improved subgroup of patients
but not in the unimproved subgroup. However, this could
be due to fewer patients in the unimproved group (%
change similar in both groups). NFL was numerically but
non-significantly reduced in all patients, except for the
unimproved group where there was a small increase.
Association between clinical measures and CSF biomarkers
Preoperative measures
In the whole sample, higher NFL correlated significantly
with poorer performance on a number of clinical tests
(MMSE, Identical forms test, Bingley's test, Romberg's test,
gait general, gait 10 m (number of steps), gait 10 m
(speed), more pronounced impairment of wakefulness
and poorer overall psychometric performance; r = 0.35–
0.64, p = 0.0001–0.04). Higher preoperative NFL corre-
lated with greater improvement in wakefulness (r = 0.46,
p  = 0.006) and non-significantly with better overall
improvement (r = 0.31, p = 0.08). Higher NFL was regis-
tered in the 9 patients with the greatest postoperative
improvement (upper 25th  percentile) than in the 9
patients with the worst postoperative outcome (lower 25th
percentile) (6415 ± 6253, mean ± SD, vs 772 ± 1010; p =
0.006, data not shown); otherwise no significant differ-
ences were seen between these two groups.
Higher tau correlated with a more pronounced impair-
ment of wakefulness (r = 0.49, p = 0.001)) and higher
albumin ratio correlated with worse psychometric per-
formance (r = 0.49, p = 0.03); otherwise no significant cor-
relations were seen between other biomarker
concentrations and clinical tests.
Postoperative measures
A more pronounced postoperative decrease in NFL corre-
lated with greater improvement in a number of tests in
both patient groups combined: gait 10 m (number of
steps, r = 0.49, p = 0.02); Romberg's test (r = 0.41, p =
0.03); gait performance index (r = 0.39, p = 0.03, Figure
1). In INPH patients, the decrease in NFL did not correlate
significantly with improvement for Rombergs test (r =
0.56) and for gait 10 m (number of steps, r = 0.55, p =
0.06).
A lower postoperative increase in tau correlated with
greater improvement in the identical forms test (r = -0.88,
p = 0.01) and MMSE (r = -0.45, p = 0.01). A lower postop-
erative increase in NPY correlated with greater improve-
ment in MMSE (r = -0.52,p = 0.01), wakefulness (r = -0.45,
p = 0.02), psychometric performance (r = -0.40, p = 0.04)
and overall improvement (r = -0.45, p = 0.02). There was
no correlation between postoperative changes in VIP,
GABA, HVA, HMPG, 5-HIAA, sulphatide or GD3 and
overall improvement after surgery, in either the total
group or in the improved patients (r < 0.36, p > 0.11).C
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Table 3: Marker concentrations in lumbar CSF pre- and postoperatively.
CSF preoperatively CSF postoperatively
Lab reference 
value
Preop SNPH 
(n = 17)
Preop INPH 
(n = 18)
Preop Improved 
(n = 28)
Preop Unimproved 
(n = 7)
Postop SNPH 
(n = 17)
Postop INPH 
(n = 18)
Postop Improved 
(n = 28)
Postop Un-improved 
(n = 7)
Protein content:
Albumin (mg/L) < 400 710 (511) pathol 544 (171) ns 650 (413) 529 (211) ns 1522 (3044) ↑ *** 1217 (1052) ↑ *** 1439 (2569) ↑ *** 1141 (935) ns
Albumin ratio < 10.2 12.2 (11.0) pathol 8.4 (3.7) ns 10.8 (8.9) 8.0 (4.6) ns 24 (46) ↑ *** 21 (22) ↑ *** 24 (40) ↑ *** 19 (17) ns
Transmitter function:
HVA (nmol/L) 253 (109) [23] 209 (146) normal 225 (155) ns 240 (154) 140 (102) ns 229 (133) ns 218 (79) ns 230 (111) ns 202 (112) ns
5-HIAA (nmol/L) 125 (54) [23] 111 (56) normal 118 (95) ns 126 (80) 74 (53) ns 119 (50) ns 123 (33) ns 127 (42) ns 96 (38) ns
HMPG (nmol/L) 47 (10) [23] 37 (15) normal 36 (16) ns 39 (16) 28 (13) ns 38 (9) ns 44 (16) ns 43 (13) ns 31 (7) ns
NPY (pmol/L) 120–170 [25] 89 (26) low 106 (36) ns 95 (30) 108 (39) ns 110 (31) ↑ *** 155 (46) ↑ *** 124 (38) ↑ *** 161 (60) ns
VIP (pmol/L) < 20 [14] 6.1 (1.7) normal 8.4 (4.9) ns 6.4 (1.4) 10.5 (7.9) ns 13 (5) ↑ *** 26 (22) ↑ ** 16 (5) ↑ *** 36 (38) ns
GABA (nmol/L) 50–130 [36] 53 (30) normal 67 (44) ns 53 (25) 80 (58) ns 84 (64) ↑ ** 103 (115) ns 91 (100) ↑ * 103 (25) ns
Demyelination:
Sulphatide (nmol/L) < 300 [24] 210 (111) normal 208 (91) ns 210 (100) 204 (105) ns 239 (116) ns 360 (318) ns 279 (245) ns 363 (195) ns
Gliosis:
GD3 (nmol/L) 50 (12) [27] 39 (25) normal 38 (22) ns 35 (22) 50 (25) ns 56 (28) ↑ * 70 (33) ↑ *** 59 (32) ↑ ** 79 (20) ns
Neuronal degeneration:
NFL (ng/L) < 300 [28] 4884 (5855) pathol 1352 (2989) ** 3637 (5338) 938 (1102) ns 3178 (4315) ns 1828 (3313) ns 2647 (3550) 2161 (1815) ns
TAU (ng/L) < 400 [26] 311 (354) normal 229 (160) ns 267 (296) 275 (165) ns 341 (174) ns 651 (256) ↑ *** 449 (248) 633 (305) ns
Values are given as mean (SD). Laboratory reference values are given in Column 1 where superscript numbers in square parentheses are literature references to laboratory reference values. INPH patients had significantly lower preoperative 
NFL than SNPH patients, as indicated in the preoperative INPH column, otherwise no differences were seen between groups preoperatively. There were no differences in preoperative CSF concentrations between improved and unimproved 
patients as indicated in the preoperative unimproved column. NFL was numerically, but not significantly, higher in the preoperative improved than in the unimproved group. There were no differences in postoperative CSF concentrations 
between improved and unimproved patients as indicated in the postoperative unimproved column. Postoperative values compared to preoperative levels are indicated in the postoperative columns. A number of markers showed significant 
increases postoperatively in the SNPH, INPH and improved groups as indicated by arrows. ns = non significant; * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001. The data for improved and unimproved patients has been published previously [18].Cerebrospinal Fluid Research 2008, 5:9 http://www.cerebrospinalfluidresearch.com/content/5/1/9
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Discussion
The main findings of this study were the correlation
between 1) a higher preoperative NFL and more severe
clinical symptoms and 2) a greater postoperative reduc-
tion in NFL and more pronounced clinical improvement.
These findings corroborate previous reports [11,18], and
give novel support to the view that the symptomatology in
NPH is caused by a periventricular neuronal dysfunction
that can be reversed by a shunt operation. Preoperatively,
the most important pathological finding was elevated
NFL in both idiopathic and secondary cases. Hypotheti-
cally, an altered periventricular microenvironment caused
by CSF flow into the white matter could lead to an axonal/
neuronal dysfunction, possibly through metabolic distur-
bance [6,30]. As a consequence, neurons may start to leak
structural proteins, such as NFL, into the interstitial fluid
and subsequently into the CSF. The higher NFL concentra-
tions seen in the secondary cases are in accordance with
the hypothetically more aggressive pathophysiological
process in secondary NPH and the more pronounced
improvement seen in these patients.
The findings of this study could be of clinical relevance for
certain patient groups. Thus, a CSF pattern of elevated NFL
but normal tau and sulphatide supports the possibility
that in patients with dementia and gait disorder, there
could be diagnostic discrimination between NPH and
Binswanger's disease, when there is increased sulphatide
[13], and Alzheimer's disease, when there is increased
tau[26].
No baseline CSF marker could identify shunt responders
with certainty, which indicates that the prognostic value
of CSF marker analysis is limited in NPH. Consistent with
a previous study [11], higher preoperative NFL concentra-
tions were correlated with more favorable outcome after
shunt surgery. However, it should be noted that there
were patients in our sample with normal NFL who
improved substantially.
Improved patients showed a postoperative reduction in
NFL, although not significant, whereas unimproved
patients showed a numerical increase in NFL. In the total
sample, no significant reduction in NFL was seen. One
reason for this could be a coexisting cerebrovascular dis-
ease in some patients causing NFL to remain elevated as
signs of cerebrovascular disease are common in NPH
[7,8,31,32]. Thus, the NFL increase could hypothetically
originate from different pathophysiological processes:
one related to CSF dynamic disturbance (NPH), another
to ischemic white matter degeneration (cerebrovascular
disease). Yet another reason could be that the follow-up
period was too short, as NFL levels remain elevated in the
CSF three months after an acute stroke episode (Lars
Rosengren, personal communication).
Scatterplot showing the relationship between postoperative reduction in NFL and improvement in gait performance index Figure 1
Scatterplot showing the relationship between postoperative reduction in NFL and improvement in gait per-
formance index.Cerebrospinal Fluid Research 2008, 5:9 http://www.cerebrospinalfluidresearch.com/content/5/1/9
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We cannot rule out that changes in some biomarkers are
related to the initial insult in SNPH patients. The time
between the initial insult and shunting in SNPH patients
was 2 months (n = 5) or = 4 months (n = 4). SNPH
patients had higher NFL levels than did INPH patients,
which favours this view. On the other hand, tau, another
neuronal marker that shows increased concentrations
after acute brain damage [33,34], did not differ between
SNPH and INPH patients. It cannot be ruled out that
hyperphosphorylated tau, which more specifically reflects
neuronal damage than total tau measured here, could dif-
fer between the groups.
The SNPH and INPH patients were analyzed separately to
allow for possible differences in pathophysiology and
comorbidity between INPH and SNPH cases. The two
groups showed a similar pattern of postoperative CSF
marker changes. Correlations similar to those of the
whole sample were observed in the INPH group between
CSF marker concentrations and clinical measures.
A possible explanation for the postoperative biochemical
changes shown in this study could be altered CSF dynam-
ics related to shunt placement, i.e. increased CSF flow
from the ventricles. However, a postoperative increase was
seen for some CSF markers but not others (monoamine
metabolites, sulphatide and NFL). This difference
between different peptides could argue against this expla-
nation since one would expect similar postoperative
changes for all markers if changes were caused by altered
CSF dynamics. Previously, it was shown that there is no
association between ventricular size and CSF marker con-
centrations which argues against the assumption that var-
iations in ventricular size explains differences in CSF
marker concentrations [18]. Also, MRI studies show very
rapid mixing of CSF within the subarachnoid space [35]
which argues against gradients caused by the shunt device.
Due to the methodological problems mentioned, the bio-
chemical alterations shown here should be interpreted
with care. Our findings indicate that there is no major
down regulation of neurotransmission in NPH as levels of
monoamine metabolites and neuropeptides remain
within normal limits both pre- and postoperatively. The
postoperative increase seen for tau could possibly be due
to a perioperative trauma to the cerebral cortex caused by
the ventricular catheter. Accordingly, tau levels remain
elevated up to five months after an acute stroke episode
[33]. The postoperative increase in albumin ratio (blood
brain barrier function), sulphatide (demyelination) and
GD3 (astrogliosis) could indicate that shunt implantation
may induce different pathological alterations in the brain.
Future CSF studies of NPH patients with longer follow-up
(12 months or more) are warranted to settle these issues.
Conclusion
A number of biochemical changes occur in the lumbar
CSF after shunt surgery, including both functional and
structural biomarkers. The results of this study indicate
that NFL could be a marker that reflects the reversible state
in NPH. Higher NFL levels occurred in patients with
greater impairment. Higher preoperative NFL levels were
also correlated with more marked clinical and functional
improvement after shunting. Additionally, a greater post-
operative reduction in NFL correlated with more pro-
nounced clinical improvement.
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